Anne Bollaerts

1.6k total citations
7 papers, 256 citations indexed

About

Anne Bollaerts is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Anne Bollaerts has authored 7 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Anne Bollaerts's work include Tuberculosis Research and Epidemiology (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Anne Bollaerts is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Anne Bollaerts collaborates with scholars based in Belgium, United States and Switzerland. Anne Bollaerts's co-authors include Marie‐Ange Demoitié, Opokua Ofori‐Anyinam, Philippe Moris, Erik Jongert, Joe Cohen, Pascal Mettens, Selvamuthu Poongulali, Nagalingeswaran Kumarasamy, Juan Antonio Solon and Salvacion Gatchalian and has published in prestigious journals such as AIDS, Medicine and Journal of Clinical Immunology.

In The Last Decade

Anne Bollaerts

7 papers receiving 249 citations

Peers

Countries citing papers authored by Anne Bollaerts

Since Specialization

Citations

This map shows the geographic impact of Anne Bollaerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Bollaerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Bollaerts more than expected).

Fields of papers citing papers by Anne Bollaerts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Bollaerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Bollaerts. The network helps show where Anne Bollaerts may publish in the future.

Co-authorship network of co-authors of Anne Bollaerts

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Bollaerts. A scholar is included among the top collaborators of Anne Bollaerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Bollaerts. Anne Bollaerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults 2018 ·Medicine ·Nagalingeswaran Kumarasamy, Selvamuthu Poongulali, (unknown), (unknown), (unknown), Anne Bollaerts, Marie‐Ange Demoitié, Erik Jongert, Opokua Ofori‐Anyinam, Olivier Van Der Meeren	24
2	A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults 2016 ·Medicine ·Nagalingeswaran Kumarasamy, Selvamuthu Poongulali, Anne Bollaerts, Philippe Moris, (unknown), (unknown), Marie‐Ange Demoitié, Erik Jongert, Opokua Ofori‐Anyinam	35
3	Safety and immunogenicity of the M72/AS01 E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study 2016 ·Tuberculosis ·Paul Gillard, Pan‐Chyr Yang, Manfred Danilovitš, Wei‐Juin Su, Shih-Lung Cheng, Lea Pehme, Anne Bollaerts, Erik Jongert, Philippe Moris, Opokua Ofori‐Anyinam, Marie‐Ange Demoitié, Marcela Castro	55
4	Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy 2014 ·AIDS ·(unknown), Matthias Cavassini, R Audran, Anne‐Christine Thierry, Anne Bollaerts, Joe Cohen, Marie‐Ange Demoitié, Dawit A. Ejigu, Pascal Mettens, Philippe Moris, Opokua Ofori‐Anyinam, François Spertini	34
5	Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: An open-label randomized controlled trial 2014 ·Tuberculosis ·Olubukola T. Idoko, Olumuyiwa Owolabi, Patrick K. Owiafe, Philippe Moris, Aderonke Odutola, Anne Bollaerts, Ezra Olatunde Ogundare, Erik Jongert, Marie‐Ange Demoitié, Opokua Ofori‐Anyinam, Martin O. C. Ota	42
6	A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults 2013 ·Journal of Clinical Immunology ·Jaime Montoya, Juan Antonio Solon, (unknown), Luz P. Acosta, Anne Bollaerts, Philippe Moris, Michel Janssens, Erik Jongert, Marie‐Ange Demoitié, Pascal Mettens, Salvacion Gatchalian, (unknown), Joe Cohen, Opokua Ofori‐Anyinam	64
7	Sample Size Considerations for Assessing Vaccine Consistency Through Equivalence 1999 ·Drug Information Journal ·Brigitte Cheuvart, Anne Bollaerts	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact